Testing heart-protection medicine during breast cancer treatment
Treatments studied
Part of Cancer, Heart & circulation, Injuries & trauma, Skin clinical trials.
This trial tests sacubitril/valsartan to help prevent heart weakness (cardiotoxicity) caused by breast cancer treatments like anthracyclines and/or anti-HER2 drugs. If you qualify, you may be offered this heart-protection medicine while your cancer is treated.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can sign consent and take pills by mouth, and you’re able to follow the study plan
- You are 18 or older and are a woman with breast cancer confirmed by pathology (biopsy/surgery samples)
- Your tumor has been checked for ER, PR, HER2, and Ki-67 (tumor growth marker)
- Your planned cancer treatment includes anthracyclines and/or anti-HER2 medicines, along with a treatment plan that includes surgery
- Your heart testing is reassuring: ejection fraction is 50% or higher, you’re in normal sinus rhythm, and your overall activity level is ECOG 0–2
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a heart medication (sacubitril/valsartan) in young cancer survivors whose hearts were weakened by anthracycline chemotherapy but are not yet having heart failure symptoms. It aims to see if the drug can improve heart function and prevent future problems.
This trial tests a drug called sacubitril/valsartan to see if it helps people who have both a prosthetic heart valve and heart failure with a weak heart pump. The goal is to improve heart function and symptoms.
This trial tests a medicine called sacubitril-valsartan for people in rural Tanzania with heart failure and reduced pumping strength. It aims to see if switching to this drug can improve symptoms and outcomes.
This study watches how chemotherapy and HER2-targeted drugs affect your heart during early-stage breast cancer treatment. Researchers use heart scans to catch any changes early and understand how to protect heart health.
This study tests whether a blood pressure pill, telmisartan, can protect the heart during chemotherapy for breast cancer. It may help reduce the risk of heart damage caused by doxorubicin (a common chemo drug).
This study tracks how well the heart handles HER2-targeted therapy (like Herceptin) during the first year of treatment for early-stage breast cancer. It helps keep you safe by checking heart function closely.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.